Non-Economic Damages Non-Economic Damages [Member] Non-Economic Damages Statistical Measurement [Domain] Statistical Measurement [Domain] Award Timing Predetermined Award Timing Predetermined [Flag] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Earnings Per Share, Basic: Earnings Per Share, Basic [Abstract] Other tax receivables Deferred Income Taxes and Other Tax Receivable, Current Pronouncements Implemented and Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Class of warrant or right, outstanding (in shares) Class of Warrant or Right, Outstanding Basic (in dollars per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Other current assets Other Assets, Miscellaneous, Current Accounts payable Increase (Decrease) in Accounts Payable, Trade Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Purchases under employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans SBI-100 SBI-100 [Member] SBI-100 Adjustment to Compensation, Amount Adjustment to Compensation Amount Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Share-Based Payment Arrangement, Option Stock options Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Income taxes Income Taxes Paid Antidilutive Securities [Axis] Antidilutive Securities [Axis] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Stock-based compensation expense Share-Based Payment Arrangement, Expense Common stock, shares authorized (in shares) Common Stock, Shares Authorized August 2023 PIPE Financing Common Stock Warrants August 2023 PIPE Financing Common Stock Warrants [Member] August 2023 PIPE Financing Common Stock Warrants Current assets Assets, Current [Abstract] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Total liabilities and stockholders’ equity Liabilities and Equity Other current liabilities Increase (Decrease) in Other Current Liabilities Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] 2021 Common Stock Warrants Two Thousand And Twenty One Common Stock Warrants [Member] Two Thousand And Twenty One Common Stock Warrants LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cover [Abstract] Total cash equivalents and marketable securities Cash and Cash Equivalents, Fair Value Disclosure Maximum Maximum [Member] General and administrative General and Administrative Expense [Member] Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Accounting Policies [Abstract] Accounting Policies [Abstract] Warrants Warrants And Derivative Liabilities [Text Block] The entire disclosure for Warrants and Derivative Liabilities. Share-based payment arrangement, plan modification, unvested awards expense not yet recognized Share-Based Payment Arrangement, Plan Modification, Unvested Awards Expense Not Yet Recognized Share-Based Payment Arrangement, Plan Modification, Unvested Awards Expense Not Yet Recognized Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] Class of Warrant or Right [Axis] Class of Warrant or Right [Axis] Payments for repurchase of warrants Payments for Repurchase of Warrants Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] 2016 Common Stock Warrants to Service Providers Two Thousand Sixteen Common Stock Warrants To Service Providers [Member] Represents two thousand sixteen Common Stock Warrants to Service Providers. Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Cancelled (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Schedule of other current assets Schedule of Other Current Assets [Table Text Block] Name Measure Name 2021 Inducement Warrants Two Thousand And Twenty One Inducement Warrants [Member] Two Thousand And Twenty One Inducement Warrants Schedule of stock-based compensation expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Operating lease liability, current portion Operating Lease, Liability, Current Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Litigation Case [Domain] Litigation Case [Domain] Award Type [Axis] Award Type [Axis] Total assets Assets Schedule of Nonvested Restricted Stock Units Activity Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Trading Symbol Trading Symbol Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Geographical [Domain] Geographical [Domain] Stock-based compensation expense (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Vendor deposits Deposits Assets, Current Entity Address, City or Town Entity Address, City or Town Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Cash paid during the year for: Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract] External clinical development expenses External Clinical Development Expenses External Clinical Development Expenses Amended And Restated Plan and 2024 Inducement Plan Amended And Restated Plan and 2024 Inducement Plan [Member] Amended And Restated Plan and 2024 Inducement Plan Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Income Statement Location [Domain] Statement of Income Location, Balance [Domain] Unvested restricted stock units Restricted Stock Units (RSUs) [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total compensatory damages Loss Contingency, Damages Awarded, Value Entity Emerging Growth Company Entity Emerging Growth Company Research and development Research and Development Expense (Excluding Acquired in Process Cost) Warrants Warrant [Member] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Changes in assets and liabilities: Increase (Decrease) in Operating Assets [Abstract] Balance at the beginning (in shares) Balance at the ending (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Loss from disposal of assets Gain (Loss) on Disposition of Other Assets Plan Name [Axis] Plan Name [Axis] PEO PEO [Member] 2021 Common Stock Warrants to Placement Agent Two Thousand And Twenty Pre Funded Warrants [Member] Two Thousand And Twenty Pre Funded Warrants. Supplemental disclosures of non-cash financing activities: Noncash Investing and Financing Items [Abstract] Interest and other income, net Investment Income, Interest Change in estimate for legal contingency Loss Contingency Accrual, Period Increase (Decrease) UNITED STATES UNITED STATES Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate Accumulated Deficit Retained Earnings [Member] Number of Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Provision for income taxes Income Tax Expense (Benefit) Economic Damages Economic Damages [Member] Economic Damages Sale of Stock [Domain] Sale of Stock [Domain] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Product and Service [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Cash, cash equivalents, and short-term investments Cash, Cash Equivalents, and Short-Term Investments Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Other current assets Increase (Decrease) in Other Current Assets Right-of-use assets Operating Lease, Right-of-Use Asset, Periodic Reduction Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Title of 12(g) Security Title of 12(g) Security City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Gain (loss) from litigation settlement Gain (Loss) from Litigation Settlement Unvested, beginning balance (in shares) Unvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Commitments and Contingencies Disclosure [Abstract] Class of Warrant or Right [Line Items] Class of Warrant or Right [Line Items] Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] General and administrative General and Administrative Expense Long-lived assets Long-Lived Assets Share-based payment arrangement, nonvested award, option, cost not yet recognized, amount Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Legal expenses Legal Professional Fee Accrual Legal Professional Fee Accrual Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Schedule of fair value assumptions of stock option granted Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Estimated loss contingency Loss Contingency, Estimate of Possible Loss PEO Total Compensation Amount PEO Total Compensation Amount Prepaid Expenses and Other Current Assets Prepaid Expenses and Other Current Assets [Member] Money Market Funds Money Market Funds [Member] Financing of D&O insurance premium Noncash Financing of Insurance Premium Noncash Financing of Insurance Premium Equity Components [Axis] Equity Components [Axis] Non-US Non-US [Member] August 2023 Convertible Note Common Stock Warrants August 2023 Convertible Note Common Stock Warrants [Member] August 2023 Convertible Note Common Stock Warrants Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Cancelled (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Organization, Basis of Presentation and Significant Accounting Policies Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Other Performance Measure, Amount Other Performance Measure, Amount Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] January 2024 Pre-Funded Warrants Common Stock January 2024 Pre-Funded Warrants Common Stock [Member] January 2024 Pre-Funded Warrants Common Stock Exercise of pre-funded warrants Stock Issued During Period, Value, Warrant Exercises Stock Issued During Period, Value, Warrant Exercises Entity Address, State or Province Entity Address, State or Province Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Total current liabilities Liabilities, Current Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract] Individual: Individual [Axis] Exercise of pre-funded warrants (in shares) Stock Issued During Period, Shares, Warrant Exercises Stock Issued During Period, Shares, Warrant Exercises Other current assets Other current assets Other Assets, Current Research and development Research and Development Expense [Member] Additional paid-in-capital Additional Paid in Capital, Common Stock Net cash provided by (used in) investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Interest Interest Paid, Excluding Capitalized Interest, Operating Activity Document Fiscal Year Focus Document Fiscal Year Focus Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use asset Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Entity Interactive Data Current Entity Interactive Data Current Plan Name [Domain] Plan Name [Domain] Recognized weighted average period (in years) Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Aggregate Intrinsic Value, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Segment Reporting Segment Reporting Disclosure [Text Block] US Treasury Securities US Treasury Securities [Member] Class of Warrant or Right [Table] Class of Warrant or Right [Table] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Depreciation and amortization Depreciation, Depletion and Amortization Other assets Other Assets, Noncurrent Entity Central Index Key Entity Central Index Key Loss contingency, appeal bond Loss Contingency, Appeal Bond Loss Contingency, Appeal Bond PEO Name PEO Name Schedule of Segment Reporting Information, by Segment [Table] Schedule of Revenues from External Customers and Long-Lived Assets [Table] Wendy Cunning Vs Skye Bioscience, Inc Wendy Cunning Vs Skye Bioscience, Inc [Member] Wendy Cunning Vs Skye Bioscience, Inc Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Arrangement Duration Trading Arrangement Duration Segments [Axis] Segments [Axis] Exercise price (in dollars per share) Class of Warrant or Right, Exercise Price of Warrants or Rights Exercise Price Award Exercise Price Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Share-based compensation arrangement by share-based payment award, discount from market price, purchase date Share-Based Compensation Arrangement by Share-Based Payment Award, Discount from Market Price, Purchase Date Stock-Based Compensation Share-Based Payment Arrangement [Text Block] Amended And Restated Plan Amended And Restated Plan [Member] Amended And Restated Plan ASSETS Assets [Abstract] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Statement of Financial Position Location, Balance [Axis] Statement of Financial Position Location, Balance [Axis] Class of Warrant or Right [Domain] Class of Warrant or Right [Domain] Fair Value Measurement Fair Value Disclosures [Text Block] Stockholders’ equity Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Total research and development expenses Research and Development Expense Operating lease liability, net of current portion Operating Lease, Liability, Noncurrent Loan payable, monthly installment, amount Loan Payable, Monthly Installment, Amount Loan Payable, Monthly Installment, Amount Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Other assets Increase (Decrease) in Other Noncurrent Assets Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Personnel related and stock-based compensation Employee Benefits and Share-Based Compensation Document Quarterly Report Document Quarterly Report Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Number of operating segments Number of Operating Segments Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Weighted Average Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Restatement Determination Date: Restatement Determination Date [Axis] Stock-based compensation expense Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Non-PEO NEO Non-PEO NEO [Member] Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Schedule of prepaid expenses Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Maturities/(purchase) of short-term investments, net of maturities Payments for (Proceeds from) Short-Term Investments Sale of Stock [Axis] Sale of Stock [Axis] Warrants and Rights Note Disclosure [Abstract] Warrants and Rights Note Disclosure [Abstract] Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Compensation Amount Outstanding Recovery Compensation Amount Dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Accrued payroll liabilities Increase (Decrease) in Employee Related Liabilities MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Unvested, beginning balance (in dollars per share) Unvested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items] Segment, Reconciliation of Other Items from Segments to Consolidated [Line Items] Weighted average shares of common stock outstanding used to compute loss per share: Weighted Average Number of Shares Outstanding Reconciliation [Abstract] Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Employee Stock Employee Stock [Member] Research and Development Activities Segment Research and Development Activities Segment [Member] Research and Development Activities Segment Stock-based compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Financial Instruments [Domain] Financial Instruments [Domain] Litigation Case [Axis] Litigation Case [Axis] Segments [Domain] Segments [Domain] Income Statement Location [Axis] Statement of Income Location, Balance [Axis] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Statement of Financial Position Location, Balance [Domain] Statement of Financial Position Location, Balance [Domain] Insurance premium loan payable Loans Payable, Current Minimum Minimum [Member] Total number of warrants issued (in shares) Class of Warrant or Right, Number of Securities Called by Warrants or Rights Repayment of insurance premium loan payable Repayments of Notes Payable Company Selected Measure Name Company Selected Measure Name Debt Debt Disclosure [Text Block] Preferred stock, $0.001 par value; 200,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Net loss Net Income (Loss) Available to Common Stockholders, Diluted All Executive Categories All Executive Categories [Member] 2021 Inducement Warrants to Placement Agent Two Thousand And Twenty One Inducement Warrants To Placement Agent [Member] Two Thousand And Twenty One Inducement Warrants To Placement Agent Common stock, $0.001 par value; 100,000,000 shares authorized at March 31, 2026 and December 31, 2025; 35,126,884 and 33,378,139 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Short-term investments Short-Term Investments Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Punitive Damages Punitive Damages [Member] Punitive Damages Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Diluted (in shares) Weighted average common shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies (Note 8) Commitments and Contingencies Share-based compensation arrangement by share-based payment award, options, vested in period, fair value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested in Period, Fair Value Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] 2024 Inducement Equity Incentive Plan 2024 Inducement Equity Incentive Plan [Member] 2024 Inducement Equity Incentive Plan Loans Payable Loans Payable [Member] Other prepaid expenses Other Prepaid Expense, Current Entity Small Business Entity Small Business Accounts payable, interest-bearing, interest rate Accounts Payable, Interest-Bearing, Interest Rate Number of Warrants Outstanding (in shares) Class Of Warrant Or Right, Warrants Vested And Outstanding Class Of Warrant Or Right, Warrants Vested And Outstanding Preferred stock, shares outstanding in shares) Preferred Stock, Shares Outstanding Document Transition Report Document Transition Report nimacimab nimacimab [Member] nimacimab Underlying Securities Award Underlying Securities Amount Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Earnings Per Share, Diluted [Abstract] Earnings Per Share, Diluted [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Weighted Average Remaining Contractual Term, Exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Operating lease liability Increase (Decrease) in Operating Lease Liability Document Type Document Type Loss Per Share of Common Stock Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Loss Contingencies [Table] Loss Contingencies [Table] Product and Service [Axis] Product and Service [Axis] Cash from asset disposition Proceeds from Sale of Other Assets, Investing Activities All Individuals All Individuals [Member] Fair Value Disclosures [Abstract] Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Working capital Working Capital Working Capital Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net loss Net Income (Loss) Available to Common Stockholders, Basic Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Current liabilities Liabilities, Current [Abstract] Weighted Average Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Geographical [Axis] Geographical [Axis] Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Diluted (in dollars per share) Earnings Per Share, Diluted Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Prepaid insurance Prepaid Insurance Number of shares issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Prepaid Expenses, Other Current Assets and Liabilities Prepaid Expenses, Other Current Assets and Liabilities [Text Block] Prepaid Expenses, Other Current Assets and Liabilities Loss per common share: Earnings Per Share [Abstract] Total other (income) expense, net Nonoperating Income (Expense) Prepaid expenses Increase (Decrease) in Prepaid Expense Schedule of anti-dilutive securities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] January 2024 PIPE Financing January 2024 PIPE Financing [Member] January 2024 PIPE Financing Segment, Reconciliation of Other Items from Segments to Consolidated [Table] Segment, Reconciliation of Other Items from Segments to Consolidated [Table] Prepaid clinical expenses Prepaid Clinical Expenses Prepaid Clinical Expenses Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Award Timing Disclosures [Line Items] Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Accrued payroll liabilities Employee-related Liabilities, Current Other research and development expenses Other Research and Development Expense Schedule of other current liabilities Other Current Liabilities [Table Text Block] Net loss Net Loss Net loss Net Income (Loss) Attributable to Parent Expiration Date Trading Arrangement Expiration Date Non-current liabilities Liabilities, Noncurrent [Abstract] Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Reclassification Reclassification, Comparability Adjustment [Policy Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Operating loss Operating loss Operating Income (Loss) Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Weighted Average Remaining Contractual Term (Years) Class Of Warrant Or Right, Term Of Warrant Class Of Warrant Or Right, Term Of Warrant Financial Instrument [Axis] Financial Instrument [Axis] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Estimate for accrued legal contingencies and related expenses Loss Contingency, Accrual, Current Share-based payment arrangement, plan modification, incremental cost Share-Based Payment Arrangement, Plan Modification, Incremental Cost Current Fiscal Year End Date Current Fiscal Year End Date Expected term (years) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Stock option, exercise price, decrease (in dollars per share) Stock Option, Exercise Price, Decrease Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Share-based compensation arrangement by share-based payment award, number of shares available for grant (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Statement [Table] Statement [Table] Other (income) expense Other Nonoperating Income (Expense) Share-based compensation arrangement by share-based payment award, maximum employee subscription rate Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Weighted-average fair value of stock options granted (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Issued Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Anti-dilutive excluded from the calculation of diluted loss per common share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount All Adjustments to Compensation All Adjustments to Compensation [Member] Amendment Flag Amendment Flag Termination Date Trading Arrangement Termination Date Net cash used in financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Schedule of stock option activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Schedule of warrants vested and outstanding Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] Basic (in shares) Weighted average common shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Intrinsic value of warrants Warrants and Rights Outstanding January 2024 PIPE Financing Pre-Funded Warrants January 2024 PIPE Financing Pre-Funded Warrants [Member] January 2024 PIPE Financing Pre-Funded Warrants Schedule of earnings per share, basic and diluted Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Other (income) expense Nonoperating Income (Expense) [Abstract] Entity Tax Identification Number Entity Tax Identification Number Research and development costs Accrued Research And Development Costs, Current Accrued Research And Development Costs, Current Balance at the beginning (in dollars per share) Balance at the ending (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Common stock, shares issued (in shares) Common Stock, Shares, Issued Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Loss Contingencies [Line Items] Loss Contingencies [Line Items] Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Total liabilities Liabilities Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating expenses Operating Expenses [Abstract] Prepaid expenses Total prepaid expenses, current Prepaid Expense, Current Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Other current liabilities Other Liabilities, Current Other accrued liabilities Other Sundry Liabilities, Current Statement [Line Items] Statement [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent Common Stock Common Stock [Member] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Consulting and professional fees Accrued Professional Fees, Current